|
Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies. |
|
|
Speakers' Bureau - Genentech (I) |
Research Funding - Rgenix |
|
|
Speakers' Bureau - Genentech |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Genentech/Roche; Immunocore; Merck |
Speakers' Bureau - Genentech/Roche; Janssen Oncology |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Janssen; Merck |
|
|
Consulting or Advisory Role - Cascadian Therapeutics (Inst); Flatiron Health; Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst) |
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Curis (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); Fujifilm (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Hutchison MediPharma (Inst); Immunomedics (Inst); Kadmon (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); Mallinckrodt (Inst); MedImmune (Inst); Medivation (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Novartis (Inst); Nucana (Inst); OncoMed (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Rgenix (Inst); Stem CentRx (Inst); Syndax (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); TetraLogic Pharmaceuticals (Inst); Verastem (Inst); Zymeworks (Inst) |
|
|
Consulting or Advisory Role - Celgene; Halozyme |
|
|
Employment - Jaguar Health; Rgenix |
Leadership - Jaguar Health; Rgenix |
Stock and Other Ownership Interests - Jaguar Health |
Research Funding - Rgenix |
|
|
|
|
Stock and Other Ownership Interests - Rgenix |
Consulting or Advisory Role - Rgenix |
Travel, Accommodations, Expenses - Rgenix |
|
|
|
Stock and Other Ownership Interests - Rgenix |
Consulting or Advisory Role - Alcobra; Baxter; Fortress Biotech; Mitra Biotech; Regeneron; Resverlogix; Sanofi |
|
|
|
|
Stock and Other Ownership Interests - Rgenix |
Patents, Royalties, Other Intellectual Property - Co-inventor on a few of Rgenix patents |
Travel, Accommodations, Expenses - Rgenix |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Rgenix |
Research Funding - Rgenix |
Patents, Royalties, Other Intellectual Property - University of Valencia |
Expert Testimony - Rgenix |
Travel, Accommodations, Expenses - Rgenix |
|
|
Stock and Other Ownership Interests - Ironwood Pharmaceuticals; Rgenix; Seachaid Pharma; Tetragenetics |
Consulting or Advisory Role - BioNevia; Catabasis; Euclises; Flexion Therapeutics; Nestle health science; Pharco Pharmaceuticals; Protagonist Therapeutics; Rgenix; Synlogic |
|
|
|
|
Stock and Other Ownership Interests - Amarin Corporation; Apellis Pharmaceuticals; Intra-Cellular Therapies; Provectus; Rgenix; TG Therapeutics; Vivus |
Consulting or Advisory Role - OrbiMed; Perry Creek Capital |
Patents, Royalties, Other Intellectual Property - Rgenix |
Other Relationship - Alliance for Cancer Gene Therapy; Potentia Pharmaceuticals |
|
|
|
|
Stock and Other Ownership Interests - rgenix |
Consulting or Advisory Role - rgenix |
Research Funding - rgenix |
Patents, Royalties, Other Intellectual Property - rgenix |
|
|
|
|
Stock and Other Ownership Interests - Rgenix |
Consulting or Advisory Role - Rgenix |
Patents, Royalties, Other Intellectual Property - Rgenix |
|
|
Honoraria - Bristol-Myers Squibb; Merck |
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Incyte; Merck; Newlink Genetics; Novartis |
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Novartis (Inst); Rgenix; Rgenix |